Skip to main content

Advertisement

SpringerLink
Log in

Disopyramide

  • Published:
Cardiac Electrophysiology Review

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wharton JM, Prystowsky EN. Disopyramide. In: Messerli FH, ed. Cardiovascular Drug Therapy. Philadelphia: WB Saunders, 1990;1324-1352.

    Google Scholar 

  2. Sasyniuk BI, Kus T. Disopyramide. In: Dagman KH, Miura DS, eds. Electrophysiology and Pharmacology of the Heart: A Clinical Guide. New York: Marcel Dekker, 1991;537-560.

    Google Scholar 

  3. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991;84:1831-1851.

    Google Scholar 

  4. Bauman JL, Gallastegui J, Strasberg B, Swiryn S, Hoff J, Welch WJ, Bauernfeind RA. Long-term therapy with disopyramide phosphate: Side effects and effectiveness. Am Heart J 1983;111:654-660.

    Google Scholar 

  5. Prystowsky EN,Waldo AL, Fisher JD. Use of disopyramide by arrhythmia specialists after the Cardiac Arrhythmia Suppression Trial: Patient selection and initial outcome. Am Heart J 1991;121:1571-1582.

    Google Scholar 

  6. Englund A, Bergfeldt L, Rosenqvist M, Disopyramide stress test: a sensitive and specific tool for predicting impending high degree atrioventricular block in patients with bifasicular block. Br Heart J 1995;74:650-655.

    Google Scholar 

  7. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-458.

    Google Scholar 

  8. The CASCADE Investigors. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). Am J Cardiol 1993;72:280-287.

    Google Scholar 

  9. Hartel G, Louhija A, Konttinen A. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion. Clin Pharmacol Ther 1974;15:551-555.

    Google Scholar 

  10. Crijns HJ, Gosselink AT, Lie KI. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: A randomized, double-blind study. PRODIS Study Group. Cardiovasc Drugs Ther 1996;10:145-152.

    Google Scholar 

  11. Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.

    Google Scholar 

  12. Pollick C. Muscular subaortic stenosis: Hemodynamic and clinical improvement after disopyramide. N Engl J Med 1982;307:997-999.

    Google Scholar 

  13. Matsubara H, Nakatani S, Nagata S, Ishikura F, Katagiri Y, Ohe T, Miyatake K. Salutary effects of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy. J Am Coll Card 1995;26:768-775.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Departments of Medicine and Physiology, University of Maryland, Baltimore, MD

    Malcolm M. Kirk & Michael R. Gold

Authors
  1. Malcolm M. Kirk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael R. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kirk, M.M., Gold, M.R. Disopyramide. Card Electrophysiol Rev 2, 189–190 (1998). https://doi.org/10.1023/A:1009928032541

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009928032541

Search

Navigation